News
Executive Order and Draft Regulations Restrict U.S. Investments in China for the First Time
Kilpatrick Earns Top Rankings in 2023 Legal 500 US
Kilpatrick Attorneys Earn Record Number of Rankings in 2023 Chambers USA
Kilpatrick Continues Tradition of Impressive Number of Attorneys Named Managing Intellectual Property IP Stars
Publications
5 Key Takeaways | International Tidbits: An Overview of Unitary Patents, Brand Protection in China, Import and Export Controls, and Compliance
Once Again, Kilpatrick Receives Top National Trademark Rankings from Managing Intellectual Property’s IP STARS
5 Key Takeaways: 35 U.S.C. § 101 in 2023 – Prosecution and Litigation Perspectives
Kilpatrick Launches New Offices
Kilpatrick Receives High Recognition from Chambers Global 2023
Kilpatrick Once Again Earns Gold-Level Rankings from World Trademark Review
Unified We Stand? The Dawn of the European Unified Patent Court and Unitary Patent
Kilpatrick Ranks As A Top 10 Firm For Most Utility Patents in 2022
Protecting Antibody Innovations: Searching for Equivalents under The Doctrine of Equivalents —A Discussion of Teva v. Eli Lilly and beyond
Patent Licensing – The Licensing Journal, Volume 42, Number 9
135 Kilpatrick Attorneys Recognized in 2022 Super Lawyers
Kilpatrick Attorneys Are Honored As 2023 IAM Global Leaders
Supreme Court Grants Amgen’s Petition for Certiorari to Reconsider Enablement of Genus Claims
5 Key Takeaways | Nuts and Bolts of NAD Proceedings: 2022 ANA Masters of Advertising Law Conference